Furthermore, hormonal changes affect chronic conditions such as lifestyle-related diseases; therefore, targeting endothelial ghrelin signaling may be a promising and specific therapeutic strategy for managing excessive adiposity and associated metabolic disorders. The gene discussed is GHRL; the disease is Other metabolic disease.